EMV Capital plc (EMVC)

Overview

EMV Capital plc is a venture capital firm with its foundation laid in 2008, having its operations centric around London, United Kingdom. The firm is carved out to specifically engage in seed, growth capital, along with early and mid-stage investments. It meticulously targets sectors such as sustainability, life sciences, technology, alongside transformative biomedical and healthcare technologies. The focus significantly leans towards investments that harbor the potential to revolutionize the digital health, diagnostics, and therapeutics sectors. Furthermore, EMV Capital demonstrates a preferential inclination towards companies committed to ameliorating the health and well-being of individuals afflicted with chronic diseases. It operates predominantly within the geographical vicinities of European developed markets, along with a notable presence in the United Kingdom and the United States. Financial commitments from EMV Capital extend up to an impressive £15 million ($20.32 million), albeit with a readiness to entertain considerations towards larger investment sums. A distinct approach of this firm lies in its preference to secure a controlling interest across all its principal subsidiaries, coupled with a strategy that involves making investments directly through its balance sheet.

Products and Services

• Digital Health Investments

  EMV Capital has a strong investment focus on digital health innovations, emphasizing on data analytics, wearable technologies, and devices. This facet of investment revolves around the pursuit of advancing healthcare through digital transformation, offering support and capital to startups and companies that are at the forefront of creating health-focused digital solutions.

• Life Science and Technology Funding

  The firm extends its financial expertise and resources to the burgeoning fields of life science and technology. Investments are targeted towards entities dedicated to introducing groundbreaking products and services within this space, aiming to catalyze significant advancements in medical, biotechnological, and healthcare technologies.

• Transformative Biomedical and Healthcare Technologies

  EMV Capital stands out for its dedication to transformative biomedical and healthcare technologies, focusing on innovations in diagnostics, therapeutics, and digital health solutions. The objective is to back companies that are working on revolutionary technologies that have the potential to significantly improve diagnostics, therapy outcomes, and overall healthcare delivery.

• Chronic Disease Health Improvement

  One of EMV Capital’s notable investment objectives is to support companies that develop solutions aimed at improving the quality of life for people with chronic diseases. Through financial backing and strategic advising, the firm contributes to the development of technologies and services that address the holistic needs of this demographic.